Ortiza, Charydel .

HRN: 21-51-43  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/27/2022
CO-AMOXICLAV 625MG (TAB)
06/27/2022
07/04/2022
PO
625
BId
Lacerated Wound
Waiting Final Action 
06/27/2022
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
06/27/2022
07/04/2022
DERMAL
25g
Bid
Burns
Waiting Final Action 
06/28/2022
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
06/28/2022
07/05/2022
DERMAL
25g
BId
Burns
Waiting Final Action 
06/30/2022
CEFTRIAXONE 1G (VIAL)
06/30/2022
07/06/2022
IV
2g
Q24
Burn Wounds
Waiting Final Action 
07/02/2022
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
07/02/2022
07/09/2022
TOPICAL
1%
Daily
Electrical Burn Injury
Waiting Final Action 
07/03/2022
MUPIROCIN 2%, 15G (TUBE)
07/03/2022
07/10/2022
ID
2%
BID
Wound Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: